Altimmune Inc (ALT)

EBITDA Growth

-19.92%

Quarterly · Period ending:

ALT logo

ALT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-19.92%
ALT Quarterly EBITDA YoY % (-2193.44% → -19.92%)
High-resolution chart · PNG

ALT ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Altimmune Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-19.9158%
-6.1604%
-14.3005%
18.9019%
11.0912%
16.7175%
22.1957%
-11.0938%
-54.2101%
-21.7526%
-40.3387%
11.7002%
20.2661%
5.7325%
1.072%
29.9691%
-19.5586%
-52.1536%
-28.1128%
-82.6045%
8.4878%
-153.6201%
-372.2404%
-66.6154%
-451.841%
-182.2792%
86.9314%
-272.4858%
68.6684%
52.9037%
-127.6767%
90.6719%
-164.9246%
-34.8025%
-396.3221%
-559.5942%
-157.2568%
-143.9144%
-529.9228%
-356.9531%
31.9967%
-181.1601%
85.0265%
76.9494%
-545.8159%
172.9441%
40.7241%
-19.474%
67.4115%
-104.1093%
-297.8981%
-120.9251%
-96.031%
57.4631%
-11.107%
70.9886%
76.0334%
-25.6334%
58.6643%
-89.9845%
56.3519%
72.8736%
59.6009%
57.3186%
19.6%
-34.6248%
-26.3677%
-115.7959%
-162.9598%
-12.9965%
15.1216%
1.5568%
364.2101%
-80.8757%
-2,114.9656%
-4.5903%
565.3229%
-1,196.0918%
56.9289%
-2,193.438%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.